FDA Drug Application (020986) for NOVOLOG by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number020986
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage1000 UNITS/10ML (100 UNITS/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVOLOG
Active IngredientINSULIN ASPART RECOMBINANT

Active IngredientCount
List of drugs with Active Ingredient INSULIN ASPART RECOMBINANT9


Back to FDA Applications sponsored by NOVO NORDISK INC